CSIMarket Company Name, Ticker, Competitors, else..
 
Ascendis Pharma A  (NASDAQ: ASND)
 

Ascendis Pharma A's Suppliers Performance

ASND's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ASND Costs vs Sales of Suppliers Growth Ascendis Pharma A recorded an increase in cost of sales by 114.46 % year on year, sequentially cost of sales grew by 306.96 % in Q4.

• More on ASND Suppliers



Ascendis Pharma A recorded increase in cost of sales by 114.46 % year on year, sequentially cost of sales grew by 306.96 % in Q4.

• More on ASND Suppliers




Ascendis Pharma A's Comment on Supply Chain


The company depends on third-party manufacturers for raw materials used in its products and product candidates and does not control the acquisition process or timing of these materials. VISEN and Teijin rely on the company for clinical and commercial supplies. Disruptions or delays in obtaining raw materials or supplier approvals from regulatory authorities, such as the FDA, could impact clinical studies, product testing, regulatory approval, and commercialization. The company may need to identify alternate suppliers to avoid supply disruptions.

Ascendis Pharma A's Comment on Supply Chain


The company depends on third-party manufacturers for raw materials used in its products and product candidates and does not control the acquisition process or timing of these materials. VISEN and Teijin rely on the company for clinical and commercial supplies. Disruptions or delays in obtaining raw materials or supplier approvals from regulatory authorities, such as the FDA, could impact clinical studies, product testing, regulatory approval, and commercialization. The company may need to identify alternate suppliers to avoid supply disruptions.







ASND's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ascendis Pharma A 15,942.09 407.28 -423.45 100
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ascendis Pharma A's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ascendis Pharma A’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.